In breast and colon cancer, VitD increased dose dependently the expression of the extracellular canonical Wnt inhibitor, DKK-1, that is associated with growth inhibition, showing a protective role of VitD against breast cancer development, progression, and metastasis [51]. This evidence concerns the gene DKK1 and breast cancer.